Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D08NAD
|
||||
Former ID |
DIB012320
|
||||
Drug Name |
Batabulin
|
||||
Synonyms |
T-138067; T-138068; T-67
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Cancer [ICD9: 140-229; ICD10:C00-C96] | Phase 2/3 | [521550] | ||
Company |
Tularik Inc
|
||||
Structure |
Download2D MOL |
||||
Formula |
C13H6F6NNaO3S
|
||||
Canonical SMILES |
S(=O)(=O)(c1c(c(c(c(c1F)F)F)F)F)Nc1cc(c(cc1)OC)F
|
||||
CAS Number |
CAS 195533-53-0
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Tubulin beta | Target Info | Inhibitor | [526170] | |
PANTHER Pathway | Cytoskeletal regulation by Rho GTPase | ||||
Huntington disease | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.